Stockreport

Vir Biotechnology Announces Pricing of Public Offering of Common Stock [Yahoo! Finance]

Vir Biotechnology, Inc.  (VIR) 
PDF SAN FRANCISCO, February 26, 2026 BUSINESS WIRE )--Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage biopharmaceutical company focused on powering the immune syste [Read more]